Patents by Inventor Thoa BUI

Thoa BUI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11446393
    Abstract: Non-viral nucleic acid delivery agents and methods for the delivery or transfer of nucleic acid molecules to target cells are disclosed. The agents comprise a complex of a nucleic acid cargo for delivery, one or more lipopeptide compound, and one or more polymeric charge-neutralising agent, and the complex is in the form of a particle with substantially neutral or negative surface charge. The agents and methods may be useful in a variety of applications such as therapies (including gene therapies and nucleic acid vaccinations) for diseases and medical disorders.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: September 20, 2022
    Assignee: Monash University
    Inventors: Colin William Pouton, Kha Tu Joan Ho, Paul James White, Catherine Thoa Bui, Nabila Akhtar, Hareth Ali Al-Wassiti
  • Publication number: 20200246487
    Abstract: Non-viral nucleic acid delivery agents and methods for the delivery or transfer of nucleic acid molecules to target cells are disclosed. The agents comprise a complex of a nucleic acid cargo for delivery, one or more lipopeptide compound, and one or more polymeric charge-neutralising agent, and the complex is in the form of a particle with substantially neutral or negative surface charge. The agents and methods may be useful in a variety of applications such as therapies (including gene therapies and nucleic acid vaccinations) for diseases and medical disorders.
    Type: Application
    Filed: June 8, 2018
    Publication date: August 6, 2020
    Inventors: Colin William POUTON, Kha Tu Joan HO, Paul James WHITE, Catherine Thoa BUI, Nabila AKHTAR, Hareth Ali AL-WASSITI
  • Publication number: 20160251441
    Abstract: Described herein is a method for separating antibody fragment impurities from target antibodies or desired fragments thereof.
    Type: Application
    Filed: October 23, 2014
    Publication date: September 1, 2016
    Applicant: MedImmune, LLC
    Inventors: Ellen T. O'CONNOR, Mutsa Y. KAMBARAMI, Matthew T. ASPELUND, Frank L. BARTNIK, Mark BERGE, Thoa BUI, Methal ALBARGHOUTHI, Jihong WANG, Jun KIM